Literature DB >> 34043674

Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan.

Samreen Sarfaraz1, Quratulain Shaikh2, Syed Ghazanfar Saleem3, Anum Rahim2, Fivzia Farooq Herekar4, Samina Junejo5, Aneela Hussain1.   

Abstract

A prospective cohort study was conducted at the Indus Hospital Karachi, Pakistan between March and June 2020 to estimate the in-hospital mortality among hospitalized COVID-19 patients and its determinants. A total of 170 adult patients were enrolled and all-cause mortality was found to be 39% (67/170). Most non-survivors were above 60 years of age (64%) while gender distribution was quite similar in both groups (males: 77% vs 78%). Most (80.6%) non-survivors came with peripheral oxygen saturation less than 93% while 95% of them had critical disease on arrival. Use of non-invasive ventilation in emergency room was higher among non-survivors (56.7%) versus survivors (26.2%). Median Interleukin-6 levels were higher among non-survivors (78.6: IQR = 33.8-49.0) compared to survivors (21.8: IQR = 12.6-36.3). Most patients in the non-survivor group (86.6%) required invasive ventilator support during hospital stay compared to 7.8% in the survivors. The median duration of ICU stay was longer for non-survivors (9: IQR = 6-12) compared to survivors (5: IQR = 3-7) days. Univariable binary logistic regression showed that age above 60 years, oxygen saturation below 93%, Neutrophil to lymphocyte ratio above 5, procalcitonin above 2ng/ml, unit increase in SOFA score and arterial lactate levels were associated with mortality. We also found that a unit decrease in Pao2/FiO2 ratio and serum albumin were associated with mortality in our patients. Multivariable regression showed that age above 60 years (aOR = 3.4: 95% CI = 1.6-6.9), peripheral oxygen saturation below 93% (aOR = 3.5:95% CI = 1.6-7.7) and serum pro-calcitonin above 2ng/ml (aOR = 4.8; 95% CI = 1.9-12.2) were associated with higher odds of mortality when adjusted by month of admission. Most common cause of death was multisystem organ failure in 35 (56.6%) non-survivors while 22 (35.5%) died due to respiratory failure. Larger prospective studies are needed to further strengthen these findings.

Entities:  

Year:  2021        PMID: 34043674     DOI: 10.1371/journal.pone.0251754

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  9 in total

1.  Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications.

Authors:  Kiran Ramzan; Sameen Shafiq; Iqra Raees; Zia Ul Mustafa; Muhammad Salman; Amer Hayat Khan; Johanna C Meyer; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-06-09

2.  Frequency and Risk Factors for Acute Kidney Injury in patients with COVID-19.

Authors:  Muhammad Anees; Omair Farooq; Muhammad Raza; Asim Mumtaz
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

3.  Trends in COVID-19: Incidence, mortality, and case fatality in Iraq.

Authors:  Nagham A Mawlood; Riyadh K Lafta
Journal:  Saudi Med J       Date:  2022-05       Impact factor: 1.422

4.  Epidemiology and Risk Factors of COVID-19-Related Mortality.

Authors:  Debarchan Barman Roy; Vandana Gupta; Shalini Tomar; Gaurav Gupta; Ashutosh Biswas; Piyush Ranjan; Upendra Baitha; Shivam Pandey; Bindoo Prakash; Naveet Wig
Journal:  Cureus       Date:  2021-12-01

5.  Effect of Remdesivir on mortality and length of stay in hospitalized COVID-19 patients: A single center study.

Authors:  Quratulain Shaikh; Samreen Sarfaraz; Anum Rahim; Mujahid Hussain; Rabeea Shah; Sara Soomro
Journal:  Pak J Med Sci       Date:  2022-01       Impact factor: 1.088

6.  Procalcitonin Levels in COVID-19 Patients Are Strongly Associated with Mortality and ICU Acceptance in an Underserved, Inner City Population.

Authors:  Theresa Feng; Alecia James; Kyra Doumlele; Seth White; Wendy Twardzik; Kanza Zahid; Zeeshan Sattar; Osato Ukponmwan; Mohamd Nakeshbandi; Lillian Chow; Robert Foronjy
Journal:  Medicina (Kaunas)       Date:  2021-10-07       Impact factor: 2.430

7.  Elevated Levels of Pleiotropic Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are Critically Involved With the Severity and Mortality of COVID-19: An Updated Longitudinal Meta-Analysis and Systematic Review on 147 Studies.

Authors:  Sarah Jafrin; Md Abdul Aziz; Mohammad Safiqul Islam
Journal:  Biomark Insights       Date:  2022-06-16

8.  "Serial ferritin titer" monitoring in COVID-19 pneumonia: valuable inflammatory marker in assessment of severity and predicting early lung fibrosis - prospective, multicentric, observational, and interventional study in tertiary care setting in India.

Authors:  Shital Patil; Gajanan Gondhali; Abhijit Acharya
Journal:  Egypt J Intern Med       Date:  2022-10-12

9.  Clinical Characteristics and Outcomes of COVID-19 Acute Respiratory Distress Syndrome Patients Requiring Invasive Mechanical Ventilation in a Lower Middle-Income Country.

Authors:  Taymmia Ejaz; Fazal Rehman; Arslan Ahmed; Safia Akhlaq; Sheema Saadia; Adil Aziz; Erfan Hussain
Journal:  J Crit Care Med (Targu Mures)       Date:  2022-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.